Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in hispanics of caribbean origin

Obesity

Volumn 18, Issue 2, 2010, Pages 327-332

  Smith, Caren E ^a   Tucker, Katherine L ^a   Lai, Chao Qiang ^a   Parnell, Laurence D ^a   Lee, Yu Chi ^a   Ordovás, José M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; LIPID; LIPOPROTEIN LIPASE;

AGED; ARTICLE; BLOOD; BODY MASS; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HISPANIC; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PROSPECTIVE STUDY; PUERTO RICO; RISK; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; UNITED STATES; WAIST CIRCUMFERENCE;

AGED; APOLIPOPROTEINS A; BODY MASS INDEX; BOSTON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PUERTO RICO; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 75749134948     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.216     Document Type: Article

References (37)

1. Pérusse L, Rankinen T, Zuberi A et al. The human obesity gene map: the 2004 update. Obes Res 2005;13:381-490.
2. Bouchard L, Tremblay A, Bouchard C, Pérusse L. Contribution of several candidate gene polymorphisms in the determination of adiposity changes: results from the Québec Family Study. Int J Obes (Lond) 2007;31:891-899.
3. Lithell H, Boberg J, Hellsing K, Lundqvist G, Vessby B. Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states. Atherosclerosis 1978;30:89-94.
4. Chen W, Srinivasan SR, Elkasabany A et al. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study. Atherosclerosis 2001;159:367-373.
5. Goodarzi MO, Taylor KD, Guo X et al. Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype. J Clin Endocrinol Metab 2007;92:293-296.
6. Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study. Int J Obes (Lond) 2006;30: 1183-1188.
7. Ukkola O, Pérusse L, Chagnon YC, Després J P, Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study. Int J Obes Relat Metab Disord 2001;25:1332-1339. (Pubitemid 32835451)
8. Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes (Lond) 2007;31:913-918.
9. Chandak GR, Ward KJ, Yajnik CS et al. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet 2006;7:76.
10. Elosua R, Cupples LA, Fox CS et al. Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: the Framingham Heart Study. Atherosclerosis 2006;189:222-228.
11. Hubacek JA, Skodová Z, Adámková V, Lánská V, Poledne R. The influence of APOAV polymorphisms (T-1131C and S19W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 2004;65:126-130.
12. Lai CQ, Tai ES, Ta n CE et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003;44:2365-2373.
13. Merkel M, Loeffler B, Kluger M et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 2005;280:21553-21560.
14. Fruchart-Najib J, Baugé E, Niculescu LS et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004;319:397-404.
15. Weinberg RB, Cook VR, Beckstead JA et al. Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 2003;278: 34438-34444.
16. Niculescu LS, Fruchart-Najib J, Fruchart JC, Sima A. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome. Clin Chem Lab Med 2007;45:1133-1139.
17. Corella D, Lai CQ, Demissie S et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007;85:119-128.
18. Marçais C, Verges B, Charrière S et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 2005;115:2862-2869.
19. Kovár J, Adámková V. Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and-1131C. Physiol Res 2008;57:555-561.
20. Dorfmeister B, Zeng WW, Dichlberger A et al. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol 2008;28:1866-1871.
21. Pennacchio LA, Olivier M, Hubacek JA et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002;11:3031-3038.
22. Hall S, Chu G, Miller G et al. A common mutation in the lipoprotein lipase gene promoter,-93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vasc Biol 1997;17:1969-1976.
23. Ehrenborg E, Clee SM, Pimstone SN et al. Ethnic variation and in vivo effects of the-93t-g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol 1997;17:2672-2678.
24. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164:1567-1587.
25. Tsai HJ, Choudhry S, Naqvi M et al. Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations. Hum Genet 2005;118:424-433.
26. Lai CQ, Tucker KL, Choudhry S et al. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet 2009;125:199-209.
27. Ruge T, Svensson M, Eriksson JW, Olivecrona G. Tissue-specific regulation of lipoprotein lipase in humans: effects of fasting. Eur J Clin Invest 2005;35:194-200.
28. Nicklas BJ, Rogus EM, Berman DM, Dennis KE, Goldberg AP. Responses of adipose tissue lipoprotein lipase to weight loss affect lipid levels and weight regain in women. Am J Physiol Endocrinol Metab 2000;279:E1012-E1019.
29. Weinstock PH, Levak-Frank S, Hudgins LC et al. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci USA 1997;94:10261-10266.
30. Kusunoki M, Tsutsumi K, Iwata K et al. NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats. Metab Clin Exp 2005;54:1587-1592.
31. McTigue K, Larson JC, Valoski A et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296:79-86.
32. Lai CQ, Demissie S, Cupples LA et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 2004;45:2096-2105.
33. Hall S, Talmud PJ, Cook DG et al. Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet Epidemiol 2000;18: 203-216.
34. Samuels ME, Forbey KC, Reid JE et al. Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the-93G/D9N variant predisposes to low HDL-C/high triglycerides. Clin Genet 2001;59:88-98.
35. Talmud PJ, Hall S, Holleran S et al. LPL promoter-93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J Lipid Res 1998;39:1189-1196.
36. Kastelein JJ, Groenemeyer BE, Hallman DM et al. The Asn9 variant of lipoprotein lipase is associated with the-93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin Genet 1998;53:27-33.
37. Wang J, Shete S. A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am J Hum Genet 2008;83:53-63.